JP2025166032A5 - - Google Patents

Info

Publication number
JP2025166032A5
JP2025166032A5 JP2025129144A JP2025129144A JP2025166032A5 JP 2025166032 A5 JP2025166032 A5 JP 2025166032A5 JP 2025129144 A JP2025129144 A JP 2025129144A JP 2025129144 A JP2025129144 A JP 2025129144A JP 2025166032 A5 JP2025166032 A5 JP 2025166032A5
Authority
JP
Japan
Prior art keywords
composition
dose
treatment
spray
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025129144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025166032A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/046023 external-priority patent/WO2019045989A1/en
Application filed filed Critical
Publication of JP2025166032A publication Critical patent/JP2025166032A/ja
Publication of JP2025166032A5 publication Critical patent/JP2025166032A5/ja
Pending legal-status Critical Current

Links

JP2025129144A 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 Pending JP2025166032A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762550656P 2017-08-27 2017-08-27
US62/550,656 2017-08-27
US201862664555P 2018-04-30 2018-04-30
US62/664,555 2018-04-30
PCT/US2018/046023 WO2019045989A1 (en) 2017-08-27 2018-08-09 METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF LYSINE SYNTHETIC ANALOGUES AND MIMETICS
JP2020532845A JP2020531586A (ja) 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2023088440A JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023088440A Division JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2025166032A JP2025166032A (ja) 2025-11-05
JP2025166032A5 true JP2025166032A5 (enExample) 2025-11-26

Family

ID=65525881

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532845A Withdrawn JP2020531586A (ja) 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A Pending JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020532845A Withdrawn JP2020531586A (ja) 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Country Status (11)

Country Link
US (2) US11413279B2 (enExample)
EP (1) EP3672584A4 (enExample)
JP (3) JP2020531586A (enExample)
KR (1) KR102706114B1 (enExample)
CN (1) CN111315374A (enExample)
AU (2) AU2018324427B2 (enExample)
BR (1) BR112020003735A2 (enExample)
CA (1) CA3073685A1 (enExample)
MX (2) MX2020002156A (enExample)
WO (1) WO2019045989A1 (enExample)
ZA (1) ZA202001472B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3156617A1 (en) * 2019-10-29 2021-05-06 W. Paul Stewart Synergistic combinations of synthetic lysine analogs, derivatives, mimetics, or prodrugs and pharmaceutical agents for enhanced efficacy
WO2021162879A1 (en) * 2020-02-14 2021-08-19 Tranexamic Technologies, Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs
JP2022132181A (ja) * 2021-02-26 2022-09-07 ライオン株式会社 コロナウイルスの細胞侵入抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0789764B1 (en) * 1994-10-28 2002-01-09 Vitaleech Bioscience N.V. A novel family of protease inhibitors, and other biologic active substances
WO2000037071A1 (en) * 1998-12-21 2000-06-29 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
US7056947B2 (en) 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
JP4600882B2 (ja) * 2002-10-11 2010-12-22 第一三共株式会社 抗インフルエンザウイルス剤
JP2008115168A (ja) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤
JP5730211B2 (ja) * 2008-11-20 2015-06-03 バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． ウイルスのアルギニン不活化
JP2010189301A (ja) * 2009-02-17 2010-09-02 Toshihito Eto 新型インフルエンザ感染症に対する医薬組成物およびその利用
US20120082677A1 (en) * 2010-10-01 2012-04-05 Sherif Salah Abdul Aziz Compositions for the treatment of hcv and hbv
US20140271923A1 (en) * 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
CN103405384B (zh) * 2013-09-01 2015-05-13 吴静 氨甲环酸的药物组合物

Similar Documents

Publication Publication Date Title
JP2025166032A5 (enExample)
KR20040038908A (ko) 바이러스 사멸 조성물
JP2024170583A5 (enExample)
CN102448438A (zh) 抗流行性感冒调配物及方法
JP2011057709A5 (enExample)
EA201000085A1 (ru) dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ
JP2009256374A5 (enExample)
JP2010285436A5 (enExample)
JP2015516975A5 (enExample)
JP2013520448A5 (enExample)
JPWO2021168403A5 (enExample)
JP2020531586A5 (enExample)
HRP20160891T1 (hr) Farmaceutski sastav koji sadrži selenit ili spojeve koji sadrže selenit za liječenje cervikalne displazije ili karcinoma cerviksa
WO2024093813A1 (zh) 核苷类化合物的制药用途
RU2015112586A (ru) Фармацевтические композиции, содержащие флурбипрофен
JP2016510332A5 (enExample)
MX2013010456A (es) Uso de una composicion pulverizable que contiene ambroxol.
WO2022041634A1 (zh) 一种预防病毒传染的复方制剂及其配制/使用方法与应用
RU2024133196A (ru) Способы лечения гриппа и поксвирусных вирусных инфекций
ES2531058T3 (es) Composiciones farmacéuticas para terapia a corto plazo con glucocorticoides
JPWO2021209174A5 (enExample)
TW200520747A (en) Medicine composition and medicine for external use containing Houttuynia cordata antiviral ingredient
US7655668B1 (en) Composition and method for treatment of warts
WO2009087005A4 (en) Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
JP7717712B2 (ja) 幹細胞組成物および組織を修復する方法